ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy.

Yunjia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.